Cargando…

Safety and Efficacy of Lysergic Acid Diethylamide-Assisted Psychotherapy for Anxiety Associated With Life-threatening Diseases

A double-blind, randomized, active placebo-controlled pilot study was conducted to examine safety and efficacy of lysergic acid diethylamide (LSD)-assisted psychotherapy in 12 patients with anxiety associated with life-threatening diseases. Treatment included drug-free psychotherapy sessions supplem...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gasser, Peter, Holstein, Dominique, Michel, Yvonne, Doblin, Rick, Yazar-Klosinski, Berra, Passie, Torsten, Brenneisen, Rudolf
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2014
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4086777/ https://www.ncbi.nlm.nih.gov/pubmed/24594678 http://dx.doi.org/10.1097/NMD.0000000000000113

Ejemplares similares

The cost-effectiveness of MDMA-assisted psychotherapy for the treatment of chronic, treatment-resistant PTSD
por: Marseille, Elliot, et al.
Publicado: (2020)

Lysergic Acid Diethylamide and Mescaline in Experimental Psychiatry
por: Freedman, Daniel X.
Publicado: (1957)

Effect of lysergic acid diethylamide (LSD) on reinforcement learning in humans
por: Kanen, Jonathan W., et al.
Publicado: (2023)

Pharmacokinetics and Pharmacodynamics of Lysergic Acid Diethylamide in Healthy Subjects
por: Dolder, Patrick C., et al.
Publicado: (2017)

Breakthrough for Trauma Treatment: Safety and Efficacy of MDMA-Assisted Psychotherapy Compared to Paroxetine and Sertraline
por: Feduccia, Allison A., et al.
Publicado: (2019)

MDMA-assisted psychotherapy for treatment of anxiety and other psychological distress related to life-threatening illnesses: a randomized pilot study
por: Wolfson, Philip E., et al.
Publicado: (2020)

Therapeutic effect of increased openness: Investigating mechanism of action in MDMA-assisted psychotherapy
por: Wagner, Mark T, et al.
Publicado: (2017)

Pharmacokinetics and Pharmacodynamics of Lysergic Acid Diethylamide Microdoses in Healthy Participants
por: Holze, Friederike, et al.
Publicado: (2020)

Lysergic Acid Diethylamide, Psilocybin and Dimethyltryptamine in Depression Treatment: A Systematic Review
por: Więckiewicz, Gniewko, et al.
Publicado: (2021)

Lysergic acid diethylamide induces increased signalling entropy in rats’ prefrontal cortex
por: Savino, Aurora, et al.
Publicado: (2021)

The effect of lysergic acid diethylamide (LSD) on whole-brain functional and effective connectivity
por: Bedford, Peter, et al.
Publicado: (2023)

Long-term follow-up outcomes of MDMA-assisted psychotherapy for treatment of PTSD: a longitudinal pooled analysis of six phase 2 trials
por: Jerome, Lisa, et al.
Publicado: (2020)

d-Lysergic Acid Diethylamide (LSD) as a Model of Psychosis: Mechanism of Action and Pharmacology
por: De Gregorio, Danilo, et al.
Publicado: (2016)

A low dose of lysergic acid diethylamide decreases pain perception in healthy volunteers
por: Ramaekers, Johannes G, et al.
Publicado: (2020)

Durability of improvement in post-traumatic stress disorder symptoms and absence of harmful effects or drug dependency after 3,4-methylenedioxymethamphetamine-assisted psychotherapy: a prospective long-term follow-up study
por: Mithoefer, Michael C, et al.
Publicado: (2013)

MDMA-assisted psychotherapy for treatment of PTSD: study design and rationale for phase 3 trials based on pooled analysis of six phase 2 randomized controlled trials
por: Mithoefer, Michael C., et al.
Publicado: (2019)

Safety, tolerability, pharmacokinetics, and pharmacodynamics of low dose lysergic acid diethylamide (LSD) in healthy older volunteers
por: Family, Neiloufar, et al.
Publicado: (2019)

Lysergic acid diethylamide (LSD) promotes social behavior through mTORC1 in the excitatory neurotransmission
por: De Gregorio, Danilo, et al.
Publicado: (2021)

Adverse experiences resulting in emergency medical treatment seeking following the use of lysergic acid diethylamide (LSD)
por: Kopra, Emma I, et al.
Publicado: (2022)

Self-inflicted neck wounds under influence of lysergic acid diethylamide: A case report and literature review
por: Le Daré, Brendan, et al.
Publicado: (2020)

Investigation of self-treatment with lysergic acid diethylamide and psilocybin mushrooms: Findings from the Global Drug Survey 2020
por: Kopra, Emma I, et al.
Publicado: (2023)

Reduction in social anxiety after MDMA-assisted psychotherapy with autistic adults: a randomized, double-blind, placebo-controlled pilot study
por: Danforth, Alicia L., et al.
Publicado: (2018)

Acute dose-dependent effects of lysergic acid diethylamide in a double-blind placebo-controlled study in healthy subjects
por: Holze, Friederike, et al.
Publicado: (2020)

3,4-Methylenedioxymethamphetamine-assisted psychotherapy for treatment of chronic posttraumatic stress disorder: A randomized phase 2 controlled trial
por: Ot’alora G, Marcela, et al.
Publicado: (2018)

Sleep Quality Improvements After MDMA‐Assisted Psychotherapy for the Treatment of Posttraumatic Stress Disorder
por: Ponte, Linnae, et al.
Publicado: (2021)

Optimized Analysis of Ergot Alkaloids in Rye Products by Liquid Chromatography-Fluorescence Detection Applying Lysergic Acid Diethylamide as an Internal Standard
por: Holderied, Iris, et al.
Publicado: (2019)

Direct comparison of the acute effects of lysergic acid diethylamide and psilocybin in a double-blind placebo-controlled study in healthy subjects
por: Holze, Friederike, et al.
Publicado: (2022)

Posttraumatic Growth After MDMA‐Assisted Psychotherapy for Posttraumatic Stress Disorder
por: Gorman, Ingmar, et al.
Publicado: (2020)

Lysergic acid diethylamide differentially modulates the reticular thalamus, mediodorsal thalamus, and infralimbic prefrontal cortex: An in vivo electrophysiology study in male mice
por: Inserra, Antonio, et al.
Publicado: (2021)

Effects of acute lysergic acid diethylamide on intermittent ethanol and sucrose drinking and intracranial self-stimulation in C57BL/6 mice
por: Elsilä, Lauri V, et al.
Publicado: (2022)

Lysergic acid diethylamide (LSD) promotes social behaviour through 5-HT(2A) and ampa in the medial prefrontal cortex (MPFC)
por: Markopoulos, A., et al.
Publicado: (2021)

Systems-level analysis of local field potentials reveals differential effects of lysergic acid diethylamide and ketamine on neuronal activity and functional connectivity
por: Nasretdinov, Azat, et al.
Publicado: (2023)

Acute Lysergic Acid Diethylamide Does Not Influence Reward-Driven Decision Making of C57BL/6 Mice in the Iowa Gambling Task
por: Elsilä, Lauri V., et al.
Publicado: (2020)

Identification of 1-Butyl-Lysergic Acid Diethylamide (1B-LSD) in Seized Blotter Paper Using an Integrated Workflow of Analytical Techniques and Chemo-Informatics
por: Tsochatzis, Emmanouil, et al.
Publicado: (2020)

Comparative acute effects of mescaline, lysergic acid diethylamide, and psilocybin in a randomized, double-blind, placebo-controlled cross-over study in healthy participants
por: Ley, Laura, et al.
Publicado: (2023)

Cytotoxic, genotoxic, and oxidative stress-related effects of lysergic acid diethylamide (LSD) and phencyclidine (PCP) in the human neuroblastoma SH-SY5Y cell line
por: Jurič, Andreja, et al.
Publicado: (2021)

PM361. The hallucinogen D-lysergic diethylamide (LSD) decreases dopamine firing activity through 5-HT(1A), D(2) and TAAR(1) receptors
por: Gregorio, Danilo De, et al.
Publicado: (2016)

Validation of a New Sensitive Method for the Detection and Quantification of R and S-Epimers of Ergot Alkaloids in Canadian Spring Wheat Utilizing Deuterated Lysergic Acid Diethylamide as an Internal Standard
por: Cherewyk, Jensen, et al.
Publicado: (2021)

Altered brain activity and functional connectivity after MDMA-assisted therapy for post-traumatic stress disorder
por: Singleton, S. Parker, et al.
Publicado: (2023)

Valyl: Valerianic Acid Diethylamid
Publicado: (1902)

Cannot write session to /tmp/vufind_sessions/sess_dlh4rpst7ift1k1pnenn37uupi